In summary, we for the first time demonstrate that CAMKIIγ plays a critical role in maintaining MM cell growth through upregulating STAT3 signaling pathway and BBM analogues might be new small molecule inhibitors for treating CAMKIIγ-dependent MM. Here, STAT3 is linked to Miyoshi myopathy.